Matches in Wikidata for { <http://www.wikidata.org/entity/Q50191084> ?p ?o ?g. }
- Q50191084 description "2018 nî lūn-bûn" @default.
- Q50191084 description "2018 թվականի փետրվարի 6-ին հրատարակված գիտական հոդված" @default.
- Q50191084 description "2018年の論文" @default.
- Q50191084 description "2018年学术文章" @default.
- Q50191084 description "2018年学术文章" @default.
- Q50191084 description "2018年学术文章" @default.
- Q50191084 description "2018年学术文章" @default.
- Q50191084 description "2018年学术文章" @default.
- Q50191084 description "2018年学术文章" @default.
- Q50191084 description "2018年學術文章" @default.
- Q50191084 description "2018年學術文章" @default.
- Q50191084 description "2018年學術文章" @default.
- Q50191084 description "2018年學術文章" @default.
- Q50191084 description "2018年學術文章" @default.
- Q50191084 description "2018년 논문" @default.
- Q50191084 description "article científic" @default.
- Q50191084 description "article scientific" @default.
- Q50191084 description "article scientifique" @default.
- Q50191084 description "articol științific" @default.
- Q50191084 description "articolo scientifico" @default.
- Q50191084 description "artigo científico" @default.
- Q50191084 description "artigo científico" @default.
- Q50191084 description "artigo científico" @default.
- Q50191084 description "artikel ilmiah" @default.
- Q50191084 description "artikull shkencor" @default.
- Q50191084 description "artikulong pang-agham" @default.
- Q50191084 description "artykuł naukowy" @default.
- Q50191084 description "artículo científico publicado en 2018" @default.
- Q50191084 description "artículu científicu" @default.
- Q50191084 description "bilimsel makale" @default.
- Q50191084 description "bài báo khoa học" @default.
- Q50191084 description "naučni članak" @default.
- Q50191084 description "scienca artikolo" @default.
- Q50191084 description "scientific article published on 6 February 2018" @default.
- Q50191084 description "scientific article published on 6 February 2018" @default.
- Q50191084 description "scientific article published on 6 February 2018" @default.
- Q50191084 description "teaduslik artikkel" @default.
- Q50191084 description "tieteellinen artikkeli" @default.
- Q50191084 description "tudományos cikk" @default.
- Q50191084 description "vedecký článok" @default.
- Q50191084 description "vetenskaplig artikel" @default.
- Q50191084 description "videnskabelig artikel" @default.
- Q50191084 description "vitenskapelig artikkel" @default.
- Q50191084 description "vitskapeleg artikkel" @default.
- Q50191084 description "vědecký článek" @default.
- Q50191084 description "wetenschappelijk artikel" @default.
- Q50191084 description "wissenschaftlicher Artikel" @default.
- Q50191084 description "επιστημονικό άρθρο" @default.
- Q50191084 description "мақолаи илмӣ" @default.
- Q50191084 description "наукова стаття, опублікована в лютому 2018" @default.
- Q50191084 description "научна статия" @default.
- Q50191084 description "научная статья" @default.
- Q50191084 description "научни чланак" @default.
- Q50191084 description "научни чланак" @default.
- Q50191084 description "מאמר מדעי" @default.
- Q50191084 description "مقالة علمية نشرت في 6 فبراير 2018" @default.
- Q50191084 description "৬ ফেব্রুয়ারি ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q50191084 description "บทความทางวิทยาศาสตร์" @default.
- Q50191084 description "სამეცნიერო სტატია" @default.
- Q50191084 name "Efficacy and safety of continuous every 2-week dosing of ixekizumab over 52 weeks in patients with moderate-to-severe plaque psoriasis in a randomized phase 3 trial (IXORA-P)." @default.
- Q50191084 name "Efficacy and safety of continuous every 2-week dosing of ixekizumab over 52 weeks in patients with moderate-to-severe plaque psoriasis in a randomized phase 3 trial" @default.
- Q50191084 type Item @default.
- Q50191084 label "Efficacy and safety of continuous every 2-week dosing of ixekizumab over 52 weeks in patients with moderate-to-severe plaque psoriasis in a randomized phase 3 trial (IXORA-P)." @default.
- Q50191084 label "Efficacy and safety of continuous every 2-week dosing of ixekizumab over 52 weeks in patients with moderate-to-severe plaque psoriasis in a randomized phase 3 trial" @default.
- Q50191084 prefLabel "Efficacy and safety of continuous every 2-week dosing of ixekizumab over 52 weeks in patients with moderate-to-severe plaque psoriasis in a randomized phase 3 trial (IXORA-P)." @default.
- Q50191084 prefLabel "Efficacy and safety of continuous every 2-week dosing of ixekizumab over 52 weeks in patients with moderate-to-severe plaque psoriasis in a randomized phase 3 trial" @default.
- Q50191084 P1433 Q50191084-CD32D3DA-6D56-4020-8303-72285DEDD181 @default.
- Q50191084 P1476 Q50191084-7185B15B-256F-4448-B6F5-F9EF90F8C539 @default.
- Q50191084 P2093 Q50191084-1206CF04-0E9C-4609-91A6-4F33A4E86C4C @default.
- Q50191084 P2093 Q50191084-410F7EAD-4BA1-4A6F-898F-3B74E0593C7C @default.
- Q50191084 P2093 Q50191084-4E96371B-7257-41DF-BC7F-DD8A0E192AF9 @default.
- Q50191084 P2093 Q50191084-5ECA6D7E-6515-4B0C-968B-DE617576B65E @default.
- Q50191084 P2093 Q50191084-79357EDA-EDF8-4846-8C79-B1D55F7619A2 @default.
- Q50191084 P2093 Q50191084-8F00F549-78EF-4645-A7C8-91DEC5FDAF22 @default.
- Q50191084 P2093 Q50191084-D6A8AB5F-A7D6-4BBC-8D65-0D25DF9B9D7A @default.
- Q50191084 P2093 Q50191084-EE5B2464-FB2E-4FFE-8678-6BD1A9F920A9 @default.
- Q50191084 P304 Q50191084-5039A292-B88E-4719-AE13-86DC71649285 @default.
- Q50191084 P31 Q50191084-10DF8A03-5F47-4451-8EF5-5D8D15285FE9 @default.
- Q50191084 P356 Q50191084-562D3175-3FEB-49A1-8BCC-DAB1F9DF9C81 @default.
- Q50191084 P407 Q50191084-14321E5D-715D-4DEC-8969-33C30B353ED8 @default.
- Q50191084 P433 Q50191084-661B406D-126D-4D2A-B3BA-0DAA6731D895 @default.
- Q50191084 P478 Q50191084-FD3A307A-84D6-417A-A7E6-E8CD3F6545E1 @default.
- Q50191084 P50 Q50191084-270C488D-E28D-4A41-B5E9-6CB224636F97 @default.
- Q50191084 P50 Q50191084-FA38F02E-05E7-4F12-8D80-4B71E65A2930 @default.
- Q50191084 P577 Q50191084-7E116559-1206-4485-90CC-8B0F3D894797 @default.
- Q50191084 P698 Q50191084-FA60CC46-8FB3-4A7B-BD9D-6BB377CA6EA5 @default.
- Q50191084 P921 Q50191084-2E665256-78B0-4CFB-B155-43F81877D238 @default.
- Q50191084 P921 Q50191084-7AE379AE-DC5C-4829-AC95-95407F86A711 @default.
- Q50191084 P356 BJD.16426 @default.
- Q50191084 P698 29405255 @default.
- Q50191084 P1433 Q4970191 @default.
- Q50191084 P1476 "Efficacy and safety of continuous every-2-week dosing of ixekizumab over 52 weeks in patients with moderate-to-severe plaque psoriasis in a randomized phase III trial (IXORA-P)" @default.
- Q50191084 P2093 "C Mallinckrodt" @default.
- Q50191084 P2093 "L Zhang" @default.
- Q50191084 P2093 "M Gooderham" @default.
- Q50191084 P2093 "N Agada" @default.
- Q50191084 P2093 "P Foley" @default.
- Q50191084 P2093 "P Polzer" @default.
- Q50191084 P2093 "R G Langley" @default.
- Q50191084 P2093 "of the IXORA-P Investigators" @default.